-
MD Anderson Cancer Center institute forms scientific advisory board
Houston-based James P. Allison Institute at the University of Texas MD Anderson Cancer Center established an 11-person scientific advisory board Aug. 15 to provide strategic guidance and evaluation to its research portfolio and programs. -
3 recent cancer treatment partnerships, alliances
Here are three cancer treatment partnerships or alliances formed since July 22. They are listed in chronological order. -
Viewpoint: How the 'pet effect' can help cancer patients
Pets offer companionship, physical activity and positive motivation. A recent survey of pet owners worldwide found that 87 percent reported a physical or mental benefit to pet ownership, wrote Ashwani Agarwal, MD, in an op-ed for the Corsicana (Texas) Daily Sun. -
UT Southwestern researchers discover brain cancer metastasis pathway
Researchers discovered a molecular pathway responsible for glioblastoma spreading to surrounding brain tissues, as well as an existing drug that hampers growth in animal models, a study in Nature Cell Biology found. -
Salem Hospital reports 2 radiation incidents
Salem (Ore.) Hospital voluntarily reported two incidents within its radiation oncology department to the U.S. Nuclear Regulatory Commission this year, The Statesman Journal reported Aug. 12. -
Moffitt Cancer Center project scrapped
The mayor of St. Petersburg rejected plans for a new Moffitt cancer center, hotel and residential tower, saying the plan didn't include enough affordable community housing, the Tampa Bay Times reported Aug. 12. -
5 recent cancer study findings
Here are five recent oncology-related studies published by Becker's since July 12, starting with the most recent: -
MD Anderson, Empyrean partner on radiation oncology treatments
Houston-based University of Texas MD Anderson Cancer Center and Empyrean Medical Systems, a technology company, entered an exclusive license and joint development agreement Aug. 10. -
Caris Precision Oncology Alliance welcomes Stephenson Cancer Center
OU Health Stephenson Cancer center has joined the Caris Precision Oncology alliance. -
New treatment method reduces brain metastasis in breast cancer patients
An Austrian study led by MedUni Vienna showed a partial or complete regression of brain metastasis in breast cancer patients after treatment with trastuzumab deruxtecan (T-Dxd). -
Oncologists' wealth, debt in 2022: 6 findings
Oncologists’ average income rose about 2 percent to $411,000 in 2022, according to Medscape's "Oncologist Wealth & Debt Report," published Aug. 5. -
Biden to appoint Dr. Monica Bertagnolli as National Cancer Institute director
President Joe Biden will appoint Monica Bertagnolli, MD, as the new director of the National Cancer Institute. -
Northwestern Medicine opens suburban Chicago cancer center
Chicago-based Northwestern Medicine expanded its cancer care to Chicago's south suburbs with the opening of the Northwestern Cancer Center Orland Park Aug. 9. -
Mount Sinai awarded 3-year grant to explore new lung tumor therapies
New York City-based Mount Sinai has been awarded a three-year, $500,000 grant from Stand Up To Cancer to explore therapeutic approaches to lung tumors with KRAS gene mutations. -
Mayo Clinic begins $233M Florida integrated oncology building
Mayo Clinic Jacksonville (Fla.) began site work on its $233 million integrated oncology building, The Jacksonville Daily Record reported Aug. 8. -
WVU Cancer Institute 1st in West Virginia to use new prostate treatment
Morganstown, W. Va-based WVU Cancer Institute became the first facility in the state to administer Pluvicto, a radiation pharmaceutical administered through injection or infusion, for a type of metastatic prostate cancer, local news website My Buckhannon reported Aug. 7. -
4 cancer research programs receiving funding over $5M
Here are four cancer research donations and grants over $5 million that Becker's has covered since June 15: -
FDA approves 1st targeted HER2-low breast cancer therapy
The FDA approved Enhertu Aug. 6, the first targeted therapy for HER2-low breast cancer. -
UVA Cancer Center receives $5.75M to battle rare blood cancers
The University of Virginia Cancer Center received gifts totaling $5.75 million from anonymous donors to speed the development of new treatments for rare blood cancers, according to an Aug. 4 press release from the university. -
Fred Hutchinson gets $25M grant for breast cancer research
Researchers at Seattle-based Fred Hutchinson Cancer Center have received a four-year, $25 million federal grant to learn how to destroy metastatic cancer cells before they can spread.
Page 39 of 50